Laura Mercer-Rosa1, Aimee Parnell, Paul R Forfia, Wei Yang, Elizabeth Goldmuntz, Steven M Kawut. 1. Division of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia and the Perelman School of Medicine, Philadelphia, Pennsylvania; Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: mercerrosal@email.chop.edu.
Abstract
BACKGROUND: Assessing right ventricular (RV) performance is essential for patients with tetralogy of Fallot (TOF). The aim of this study was to investigate the reliability and validity of tricuspid annular plane systolic excursion (TAPSE) against cardiac magnetic resonance imaging measures and cardiopulmonary exercise testing. METHODS: A retrospective study was performed in 125 outpatients with repaired TOF with available protocol-driven echocardiography, cardiac magnetic resonance imaging, and exercise stress testing obtained as part of a cross-sectional study. TAPSE was measured on the two-dimensional apical four-chamber view on echocardiography by two readers. Multivariate linear regression was used to examine the association between TAPSE and measures of RV function and exercise capacity. RESULTS: The mean age was 12.6 ± 3.3 years, 41 patients (33%) were female, and 104 (83%) were white. TAPSE averaged 1.6 ± 0.37 cm, with an interreader intraclass correlation coefficient of 0.78 (n = 18). TAPSE was significantly associated with cardiac magnetic resonance-based RV stroke volume after adjustment for gender and body surface area (β = 13.8; 95% confidence interval, 2.25-25.30; P = .02). TAPSE was not associated with cardiac magnetic resonance-based RV ejection fraction (P = .77). On exercise testing, TAPSE was not associated with peak oxygen consumption, percentage of predicted oxygen consumption, oxygen pulse, or the ventilatory equivalent for carbon dioxide in patients with maximal exercise stress testing (n = 73 [58%]). CONCLUSIONS: TAPSE is reproducibly measured by echocardiography in patients with TOF. It is not associated with RV ejection fraction or exercise performance, and its association with RV stroke volume may be confounded by body size. On the basis of these results, TAPSE is not representative of global RV performance in patients with TOF.
BACKGROUND: Assessing right ventricular (RV) performance is essential for patients with tetralogy of Fallot (TOF). The aim of this study was to investigate the reliability and validity of tricuspid annular plane systolic excursion (TAPSE) against cardiac magnetic resonance imaging measures and cardiopulmonary exercise testing. METHODS: A retrospective study was performed in 125 outpatients with repaired TOF with available protocol-driven echocardiography, cardiac magnetic resonance imaging, and exercise stress testing obtained as part of a cross-sectional study. TAPSE was measured on the two-dimensional apical four-chamber view on echocardiography by two readers. Multivariate linear regression was used to examine the association between TAPSE and measures of RV function and exercise capacity. RESULTS: The mean age was 12.6 ± 3.3 years, 41 patients (33%) were female, and 104 (83%) were white. TAPSE averaged 1.6 ± 0.37 cm, with an interreader intraclass correlation coefficient of 0.78 (n = 18). TAPSE was significantly associated with cardiac magnetic resonance-based RV stroke volume after adjustment for gender and body surface area (β = 13.8; 95% confidence interval, 2.25-25.30; P = .02). TAPSE was not associated with cardiac magnetic resonance-based RV ejection fraction (P = .77). On exercise testing, TAPSE was not associated with peak oxygen consumption, percentage of predicted oxygen consumption, oxygen pulse, or the ventilatory equivalent for carbon dioxide in patients with maximal exercise stress testing (n = 73 [58%]). CONCLUSIONS:TAPSE is reproducibly measured by echocardiography in patients with TOF. It is not associated with RV ejection fraction or exercise performance, and its association with RV stroke volume may be confounded by body size. On the basis of these results, TAPSE is not representative of global RV performance in patients with TOF.
Authors: Lawrence G Rudski; Wyman W Lai; Jonathan Afilalo; Lanqi Hua; Mark D Handschumacher; Krishnaswamy Chandrasekaran; Scott D Solomon; Eric K Louie; Nelson B Schiller Journal: J Am Soc Echocardiogr Date: 2010-07 Impact factor: 5.251
Authors: Eirik Pettersen; Thomas Helle-Valle; Thor Edvardsen; Harald Lindberg; Hans-Jørgen Smith; Bjarne Smevik; Otto A Smiseth; Kai Andersen Journal: J Am Coll Cardiol Date: 2007-06-11 Impact factor: 24.094
Authors: Peter Morcos; G Wesley Vick; David J Sahn; Michael Jerosch-Herold; Alan Shurman; Florence H Sheehan Journal: Int J Cardiovasc Imaging Date: 2008-12-02 Impact factor: 2.357
Authors: Alessandro Giardini; Salvatore Specchia; Theresa Ann Tacy; Gloria Coutsoumbas; Gaetano Gargiulo; Andrea Donti; Roberto Formigari; Marco Bonvicini; Fernando Maria Picchio Journal: Am J Cardiol Date: 2007-04-05 Impact factor: 2.778
Authors: Martin Koestenberger; William Ravekes; Allen D Everett; Hans Peter Stueger; Bernd Heinzl; Andreas Gamillscheg; Gerhard Cvirn; Arnulf Boysen; Andrea Fandl; Bert Nagel Journal: J Am Soc Echocardiogr Date: 2009-05-07 Impact factor: 5.251
Authors: Nicole J Sutton; Lynn Peng; James E Lock; Peter Lang; Gerald R Marx; Tracy J Curran; Julie-Ann O'Neill; Sarah T Picard; Jonathan Rhodes Journal: Am Heart J Date: 2007-10-17 Impact factor: 4.749
Authors: Shivani M Bhatt; Yan Wang; Okan U Elci; Elizabeth Goldmuntz; Michael McBride; Stephen Paridon; Laura Mercer-Rosa Journal: J Am Soc Echocardiogr Date: 2018-09-27 Impact factor: 5.251
Authors: David J Goldberg; Benjamin French; Anita L Szwast; Michael G McBride; Stephen M Paridon; Jack Rychik; Laura Mercer-Rosa Journal: Echocardiography Date: 2016-09-05 Impact factor: 1.724
Authors: Brian R White; Hannah Katcoff; Jennifer A Faerber; Kimberly Y Lin; Joseph W Rossano; Laura Mercer-Rosa; Matthew J O'Connor Journal: J Am Soc Echocardiogr Date: 2019-04 Impact factor: 5.251
Authors: Kiona Y Allen; Shannon Jones; Tannoa Jackson; Grace DeCost; Paul Stephens; Brian D Hanna; Meryl S Cohen; Kim Smith-Whitley; Laura Mercer-Rosa; Shobha S Natarajan Journal: Pediatr Cardiol Date: 2019-09-21 Impact factor: 1.655
Authors: Matthew J Campbell; Michael D Quartermain; Meryl S Cohen; Jennifer Faerber; Oluwatimelehin Okunowo; Yan Wang; Valerie Capone; Jenna DiFrancesco; Laura Mercer-Rosa; David J Goldberg Journal: Echocardiography Date: 2020-08-13 Impact factor: 1.724